Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 4Phase 4 3Phase 1 3Phase NA 2Phase EARLY_PHASE1 2Phase 3 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Breast 1

Conditions

Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Mycoses 1Leukemia 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Bone Marrow Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Interventional × posaconazole × Clear all
NCT06802757 2026-02-25

PRISM-TNBC

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
72 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06541067 2026-01-26

POSALLO

Nantes University Hospital

Phase 2 Recruiting
30 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 15 charts
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT00936117 2019-02-27

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
25 enrolled 5 charts
Other hematologic neoplasm

Leukemia, Mycoses, Bone Marrow Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡